Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izeradjene, K.
Right arrow Articles by Houghton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izeradjene, K.
Right arrow Articles by Houghton, J. A.
Clinical Cancer Research Vol. 11, 5329, July 15, 2005
© 2005 American Association for Cancer Research

Letters to the Editor

Acknowledgment and Apology: Text Copied from Biochemical Journal

Kamel Izeradjene, Leslie Douglas, Addison Delaney and Janet A. Houghton

St. Jude Children's Research Hospital, Memphis, Tennessee

To the Editor:

This letter serves as an acknowledgment that in the Introduction section of our article on the influence of casein kinase II on human rhabdomyosarcoma cells published in Clinical Cancer Research (1), the text of paragraph 2, lines 7 through 42 on page 6651 was directly copied from an article by David W. Litchfield in Biochemical Journal (2).

Further, segments of the Discussion section on page 6658 of our article were also copied from the article in Biochemical Journal, specifically, column 1, paragraph 1, lines 10 through 19, and column 2, lines 6 through 10.

We sincerely regret this error and wish to offer the assurance that it was an oversight and was unintentional. We offer our genuine and most sincere apology to Dr. Litchfield and the Biochemical Journal and to the readers of Clinical Cancer Research.

References

  1. Izeradjene K, Douglas L, Delaney A, Houghton JA. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res 2004;10:6650–60.[Abstract/Free Full Text]
  2. Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions and death. Biochem J 2003;369:1–15.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izeradjene, K.
Right arrow Articles by Houghton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izeradjene, K.
Right arrow Articles by Houghton, J. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online